GLP-1 drug enters trial for progressive multiple sclerosis

Neuroscience-supported research examines whether long-term therapy can slow brain damage after progressive multiple sclerosis. GLP-1 drugs have been nearly impossible to escape as they dominate weight loss, celebrity culture, diabetes care, and the future of medicine itself. Drugs in this…












